PubMed Health⌕ Search

Biomedical subjects

N E Anderson

Publications and source records attributed to N E Anderson.

At least 37 records · Page 2Linked to original sources
PubMed1997

Herpes simplex encephalitis treated with acyclovir: diagnosis and long term outcome.

OBJECTIVES: The frequency and characteristics of the long term sequelae of herpes simplex encephalitis were assessed after treatment with acyclovir. METHODS: Patients were included if they were treated with acyclovir and the diagnosis of herpes simplex encephalitis was confirmed by culture of herpes simplex virus (HSV) from the brain, an increase in the CSF HSV antibody titre, or detection of HSV deoxyribonucleic acid in the CSF. Each patient's medical records were reviewed and surviving patients were interviewed and examined. RESULTS: A diagnosis of herpes simplex encephalitis was confirmed in 42 patients. Five patients (12%) died in the first month. Three patients (7%) had severe neurological sequelae and died after a longer interval. All but one of the 34 surviving patients had neurological symptoms, an abnormal neurological examination, or both. Twenty patients (48%) performed everyday activities as well as before herpes simplex encephalitis; nine patients (21%) were living independently, but were functioning at a lower level than before the illness; and five patients (12%) had a severe neurological deficit. Twenty nine of the 34 survivors were assessed six months to 11 years after herpes simplex encephalitis. The most common long term symptoms were memory impairment (69%), personality and behavioural abnormalities (45%), and epilepsy (24%). Short term memory impairment (70%), anosmia (65%), and dysphasia (41%) were the most common signs. CONCLUSIONS: Although acyclovir has reduced the mortality of herpes simplex encephalitis, 30% of this group of patients either died or had a severe neurological deficit. The other 70% of the patients regained independence in activities of daily living, but most of these people had persistent neurological symptoms, signs, or both.

Acyclovir↗
PubMed1997

Anterior opercular syndrome, caused by herpes simplex encephalitis.

Bilateral frontal and parietal opercular lesions cause a syndrome characterized by paralysis of the masticatory, facial, pharyngeal, and tongue muscles (the anterior opercular syndrome). The anterior opercular syndrome can occur in patients with herpes simplex encephalitis (HSE), but in most of these patients the diagnosis of HSE was not confirmed. We describe the anterior opercular syndrome in four patients with HSE. In two of these patients, the anterior opercular syndrome dominated the clinical picture, but in the other two patients it was overshadowed by other manifestations of HSE. The diagnosis of HSE was confirmed by detection of herpes simplex virus (HSV) DNA in the CSF (two patients), culture of the HSV from a brain biopsy (one patient), and elevated HSV antibody titers in the CSF (one patient). Our patients made a partial recovery. Acute onset of weakness of masticatory, facial, pharyngeal, and glossal muscles, accompanied by fever, headache, and partial motor seizures of the face should suggest HSE.

Adolescent↗
PubMed1997

The long-term neuropsychological outcome of herpes simplex encephalitis in a series of unselected survivors.

This study sought to produce a cognitive profile of herpes simplex encephalitis (HSE) survivors from a large group of definitively diagnosed, acyclovir-treated participants. Results from 22 adults who underwent a battery of neuropsychological tests indicated anterograde memory dysfunction to be the most severe and common deficit (although the variation was great), with less severe and less frequent impairments in the areas of retrograde memory, executive functions, and language functioning. Overall, neuropsychological outcome was unimpaired in six participants, mildly impaired in thirteen, moderately impaired in one, severely impaired in two. Older participants and those with a lower level of consciousness before the start of treatment produced poorer scores on certain aspects of cognitive outcome (p < 0.05). A significantly better cognitive outcome was found in participants for whom there was a short delay (fewer than 5 days) between symptom onset and acyclovir treatment compared with those participants for whom there was a longer delay. The two children in the study had disparate results on most tests, the exception being those assessing memory functioning on which both children had scores at population norms. On a naming task designed to explore category-specific knowledge deficits, the adults as a group made more errors on pictures of living things than nonliving things (matched pair-wise for word frequency and visual familiarity), although this difference disappeared on a smaller subset of pictures also matched for visual complexity.

Acyclovir↗
PubMed1996

Intestinal pseudo-obstruction, myasthenia gravis, and thymoma.

Two patients presented with abdominal pain, recurrent vomiting, weight loss, and constipation secondary to intestinal pseudo-obstruction. Both patients had symptoms and signs of myasthenia gravis, acetylcholine receptor antibodies, and thymoma. In one patient inflammatory cell infiltrates and occasional degenerate neurons were found in the myenteric plexus. The gastrointestinal symptoms resolved during treatment with pyridostigmine. The close temporal relationship between the onset of the gastrointestinal symptoms and the detection of myasthenia gravis and thymoma suggests that intestinal pseudo-obstruction can be a paraneoplastic syndrome associated with thymoma.

Aged↗
PubMed1995

Approaches to the problems of measuring the incidence of stroke: the Auckland Stroke Study, 1991-1992.

BACKGROUND: Stroke registers are the preferred choice for determining incidence, case-fatality and severity of acute stroke in defined populations. This paper highlights some of the problems likely to be encountered in this endeavour by describing the experience of measuring acute stroke prospectively. METHODS: The Auckland Stroke Study is a community-based study among 945,000 residents of the Auckland region, New Zealand. Standard definitions and overlapping case-finding methods were used to identify all new acute stroke events occurring during the 12-month period ending 1 March 1992. Particular attention was directed at including non-fatal strokes managed outside hospital. The latter were identified by use of a cluster sample, a technique suitable for populations where residents have a personal primary health care physician. RESULTS: The comprehensive sources of referral to the study involved the review of 5736 records, less than one-third of which met the criteria for inclusion. The majority of included acute stroke events (n = 1803) were found through routinely available sources such as hospital admission records (63%) and death registrations (10%). The remainder (27%) were identified through intensive efforts at case-finding of stroke events managed outside hospital. The 1803 events were registered in 1761 people, 817 men and 944 women; for 587 (72%) men and 718 (76%) women, the stroke was the first ever experienced. CONCLUSIONS: While time-consuming, costly and demanding, there appears to be no easier alternative to a register to estimate incidence. This study demonstrates the importance of the use of comprehensive case-finding sources and suggests approaches to overcoming the difficulties in monitoring stroke incidence in large populations.

Adolescent↗
PubMed1995

The immunobiology and clinical features of paraneoplastic syndromes.

Several antineuronal antibodies have been found in patients with neurological paraneoplastic syndromes. In the past year the spectrum of clinical manifestations associated with these antibodies has expanded. New information on the characteristics of the inflammatory infiltrates in the nervous system of affected patients, and on the function and distribution of the neuronal antigens has become available. Studies have examined the possible role of antibodies in the pathogenesis of paraneoplastic disorders.

Antibodies↗
PubMed1995

Leptomeningeal and brain biopsy in chronic meningitis.

BACKGROUND: The cause is not found in one third of patients presenting with chronic meningitis. Biopsy of the leptomeninges and brain is often recommended in these patients, but the value of a biopsy is uncertain. AIMS: To review the results of leptomeningeal and brain biopsies and their effect on diagnosis and management in patients with chronic meningitis, if the diagnosis was uncertain after clinical assessment, lumbar puncture and radiological investigations. METHODS: The clinical features, investigations and the results of leptomeningeal and brain biopsies were reviewed retrospectively in 25 patients presenting with chronic meningitis between 1967 and 1990. RESULTS: The biopsy identified the cause of the chronic meningitis in five patients (neoplastic meningitis in three, tuberculous meningitis in one, granulomatous angiitis in one). In 17 patients the biopsy was abnormal but it did not identify the cause (non-granulomatous lymphocytic meningitis in eight, granulomatous meningitis in two, non-specific abnormalities in seven). In two patients the biopsy was normal and in one patient the tissue was used only for culture. The results of the biopsy led to a beneficial change in treatment in two patients but did not influence management in the other patients. CONCLUSIONS: A leptomeningeal and brain biopsy was of limited practical value in diagnosis and management in most patients with chronic meningitis.

Adolescent↗
PubMed1995

Inadequacy of clinical scoring systems to differentiate stroke subtypes in population-based studies.

BACKGROUND AND PURPOSE: We undertook to examine the usefulness for epidemiological studies of two well-known validated clinical scoring methods, the Guys' Hospital Stroke score and the Siriraj Hospital Stroke score, to classify strokes into the two main types, hemorrhagic and ischemic, in epidemiological studies. METHODS: Patients from a population-based stroke register who received either a CT scan or an autopsy were retrospectively scored using the two clinical scoring methods. The scores were then compared with the CT scan and autopsy results to determine the sensitivity, specificity, and positive predictive value for intracranial hemorrhage (primary intracerebral and subarachnoid hemorrhage) and ischemic stroke. RESULTS: Over a 12-month period, 554 patients from a population-based study underwent CT scanning. Films or autopsy reports were available for 521 patients, and of these, sufficient clinical information to calculate the Guys' Hospital Stroke score and the Siriraj Hospital Stroke score was available for 464 and 475 patients, respectively. For the Guys' Hospital Stroke score, the sensitivity and specificity for intracranial hemorrhage were 31% and 95%, respectively; the positive predictive value was 73%. The sensitivity and specificity for ischemic stroke were 78% and 70%, respectively, and the positive predictive value was 86%. For the Siriraj Hospital Stroke score, the sensitivity and the specificity for intracranial hemorrhage were 48% and 85%, respectively; the positive predictive value was 59%. The sensitivity and specificity for ischemic stroke were 61% and 74%, respectively, and the positive predictive value was 84%. CONCLUSIONS: This validation study suggests that both clinical scores lack sufficient validity to be used in epidemiological studies for classification of stroke types and should probably not be used in the randomization of patients into treatment trials using thrombolytic or antithrombotic drugs in the absence of diagnostic information based on neuroimaging techniques.

Adult↗
PubMed1994

Stroke incidence and case fatality in Australasia. A comparison of the Auckland and Perth population-based stroke registers.

BACKGROUND AND PURPOSE: Population-based studies are crucial for identifying explanations for the decline in mortality from stroke and for generating strategies for public health policy. However, the present particular methodological difficulties, and comparability between them is generally poor. In this article we compare the incidence and case fatality of stroke as assessed by two independent well-designed incidence studies. METHODS: Two registers of acute cerebrovascular events were compiled in the geographically defined metropolitan areas of Auckland, New Zealand (population 945,369), during 1991-1992 for 12 months and Perth, Australia (population 138,708), during 1989-1990 for 18 months. The protocols for each register included prospective ascertainment of cases using multiple overlapping sources and the application of standardized definitions and criteria for stroke and case fatality. RESULTS: In Auckland, 1803 events occurred in 1761 residents, 73% of which were first-ever strokes. The corresponding figures for Perth were 536 events in 492 residents, 69% of which were first-ever strokes. Both studies identified a substantial proportion of nonfatal strokes managed solely outside the hospital system: 28% in Auckland and 22% in Perth of all patients registered. The age-standardized annual incidence of stroke (all events) was 27% higher among men in Perth compared with Auckland (odds ratio, 1.27; P = .016); women tended to have higher rates in Auckland, although these differences were not statistically significant. In both centers approximately a quarter of all patients died within the first month after a stroke. There were significant differences in the prevalence of hypertension among first-ever strokes. CONCLUSIONS: These two studies emphasize the importance of identifying all patients with stroke, both hospitalized and nonhospitalized, in order to measure the incidence of stroke accurately. The incidence and case fatality of stroke were remarkably similar in Auckland and Perth in the early 1990s. However, there are differences in the sex-specific rates that correspond to differences in the pattern of risk factors.

Adolescent↗
PubMed1993

A polymerase chain reaction assay of cerebrospinal fluid in patients with suspected herpes simplex encephalitis.

A polymerase chain reaction (PCR) was used to detect herpes simplex virus (HSV) deoxyribonucleic acid (DNA) in CSF of 109 patients with possible herpes simplex encephalitis. HSV DNA was found in 20/109 patients. In 14 of these patients the diagnosis was confirmed by a rise in CSF antibodies, isolation of HSV from the brain, or both. In 3 patients CSF antibodies did not rise and 3 patients did not have a follow up lumbar puncture or a brain biopsy. In 19/20 patients HSV DNA was present in the first CSF specimen. The virus was identified as HSV I in 15 patients and HSV II in 4; the virus was not typed in the other patient. A possible diagnosis of herpes simplex encephalitis was not confirmed in the 89 PCR-negative patients. HSV DNA was present in CSF of 3 patients who had meningitis with herpetic genital infections but it was not found in 24 patients with other neurological diseases. The results suggest that the detection of HSV DNA in CSF using a PCR assay will be an accurate method of early diagnosis of herpes simplex encephalitis.

Adolescent↗
PubMed1991

Cryptococcal meningitis in Auckland 1969-89.

Twenty-six patients with cryptococcal meningitis were seen in Auckland between 1969 and 1989. The incidence of cryptococcal meningitis in Auckland residents was 0.12 cases/100,000/year. Ten (38%) of the patients were Maori or Pacific Island Polynesians. Nineteen (73%) had a predisposing cause, including immunosuppressive therapy in nine and the acquired immunodeficiency syndrome (AIDS) in seven. The most common presenting syndrome was a subacute or chronic meningitis. Other clinical syndromes included a slowly progressive ataxia, polyradiculopathy, and headache with vomiting. In two patients, the symptoms of meningitis were overshadowed by those of systemic cryptococcal infection. Delay in making the diagnosis was common. The most sensitive method for diagnosing cryptococcal meningitis was the cerebrospinal fluid cryptococcal antigen test. Antifungal therapy cured 17 of the 25 (68%) treated patients overall, 15 of the 19 (79%) without AIDS and six of the seven with no underlying disease.

Acquired Immunodeficiency Syndrome↗
PubMed1991

Brain biopsy in the management of focal encephalitis.

The value of a brain biopsy in diagnosis and management of suspected herpes simplex encephalitis was studied in 29 patients (16 prospectively and 13 retrospectively). The biopsy showed herpes simplex encephalitis in eight, culture-negative encephalitis in 14, and was normal in three patients. It provided an alternative diagnosis in four patients, for two of whom curative treatment was available. The biopsy was complicated by a fatal intracranial haemorrhage in one patient. The low yield of alternative diagnoses suggests that a brain biopsy is not justified in the routine investigation of focal encephalitis.

Adolescent↗
PubMed1989

Anti-neuronal autoantibodies and neurological paraneoplastic syndromes.

Remote effects of cancer on the nervous system or paraneoplastic syndromes are diseases of unknown cause that occur exclusively or with increased frequency in patients with cancer. Several hypotheses have been used to explain the pathogenesis of these disorders. One hypothesis is that the tumour and the nervous system share antigens, so that an autoimmune response generated against the tumour causes the neurological disorder. The best evidence for this hypothesis is found in the Lambert-Eaton myasthenic syndrome which can be transferred to animals by injecting them with IgG from patients. The identification of autoantibodies against Purkinje cell cytoplasmic protein antigens in patients with paraneoplastic cerebellar degeneration, autoantibodies against neuronal nuclear antigens in patients with paraneoplastic syndromes associated with small cell lung cancer and autoantibodies against retinal ganglion cells in patients with small cell lung cancer and retinal degeneration supports this hypothesis. The possible role of these autoantibodies in the pathogenesis of paraneoplastic neurological disease is discussed.

Autoantibodies↗